Sukari A - Search Results

1

Is this really just "fatigue"? A case series of immune-related central adrenal insufficiency secondary to immune checkpoint inhibitors.

Nagasaka M, Abdallah N, Samantray J, Sukari A. Nagasaka M, et al. Among authors: sukari a. Clin Case Rep. 2018 May 24;6(7):1278-1281. doi: 10.1002/ccr3.1567. eCollection 2018 Jul. Clin Case Rep. 2018. PMID: 29988586 Free PMC article.

2

Cancer Immunology and Immunotherapy.

Sukari A, Nagasaka M, Al-Hadidi A, Lum LG. Sukari A, et al. Anticancer Res. 2016 Nov;36(11):5593-5606. doi: 10.21873/anticanres.11144. Anticancer Res. 2016. PMID: 27793882 Review.

3

PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report.

Nagasaka M, Zaki M, Kim H, Raza SN, Yoo G, Lin HS, Sukari A. Nagasaka M, et al. Among authors: sukari a. J Immunother Cancer. 2016 Nov 15;4:83. doi: 10.1186/s40425-016-0187-0. eCollection 2016. J Immunother Cancer. 2016. PMID: 27895920 Free PMC article.

4

Role of Molecular Profiling in Diagnosis of Papillary Renal-cell Cancer Presenting as Cancer of Unknown Primary Site.

Nagasaka M, Kukreja G, Abdulfatah E, Vaishampayan U, Sukari A. Nagasaka M, et al. Among authors: sukari a. Clin Genitourin Cancer. 2017 Aug;15(4):e713-e717. doi: 10.1016/j.clgc.2016.11.004. Epub 2016 Dec 1. Clin Genitourin Cancer. 2017. PMID: 28024951 No abstract available.

5

Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.

Nagasaka M, Zaki M, Issa M, Kim H, Abrams J, Sukari A. Nagasaka M, et al. Among authors: sukari a. Laryngoscope. 2017 Oct;127(10):2260-2264. doi: 10.1002/lary.26554. Epub 2017 Mar 8. Laryngoscope. 2017. PMID: 28271529 Free PMC article.

6

EGFR-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing.

Sukari A, Nagasaka M, Wakeling E. Sukari A, et al. J Natl Compr Canc Netw. 2017 Oct;15(10):1188-1192. doi: 10.6004/jnccn.2017.7014. J Natl Compr Canc Netw. 2017. PMID: 28982744

7

Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.

Sukari A, Nagasaka M, Abdallah N. Sukari A, et al. Oral Oncol. 2018 May;80:100-102. doi: 10.1016/j.oraloncology.2018.03.011. Epub 2018 Mar 28. Oral Oncol. 2018. PMID: 29605290

8

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation.

Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A. Abdallah N, et al. Among authors: sukari a. Lung Cancer (Auckl). 2018 Oct 25;9:85-90. doi: 10.2147/LCTT.S173724. eCollection 2018. Lung Cancer (Auckl). 2018. PMID: 30498383 Free PMC article.

9

Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution.

Sukari A, Nagasaka M, Alhasan R, Patel D, Wozniak A, Ramchandren R, Vaishampayan U, Weise A, Flaherty L, Jang H, Kim S, Gadgeel S. Sukari A, et al. Anticancer Res. 2019 Feb;39(2):781-790. doi: 10.21873/anticanres.13175. Anticancer Res. 2019. PMID: 30711957 Free PMC article.

10

Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.

Sukari A, Nagasaka M, Diab M, Al Sibai K, Atassi B, Elayoubi JA, Kim S, Küçük Ö. Sukari A, et al. Clin Otolaryngol. 2019 Jul;44(4):639-643. doi: 10.1111/coa.13316. Epub 2019 Apr 1. Clin Otolaryngol. 2019. PMID: 30784192 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters